Log in

LON:GNS - Genus Share Price, Forecast & News

GBX 3,164
-90.00 (-2.77 %)
(As of 04/3/2020 05:32 AM ET)
Today's Range
3,124
Now: GBX 3,164
3,280
50-Day Range
2,694
MA: GBX 3,180.80
3,644
52-Week Range
2,158
Now: GBX 3,164
3,709.98
Volume31,938 shs
Average Volume78,154 shs
Market Capitalization£2.06 billion
P/E Ratio54.93
Dividend Yield0.94%
BetaN/A
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos, which are delivered through artificial insemination to breed dairy and beef cattle with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in vitro fertilization, reproductive, and other technical services to farmers; and agricultural and agri-food consultancy services. Genus plc was incorporated in 1994 and is headquartered in Basingstoke, the United Kingdom.
Read More
Genus logo

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1256-347100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£520.40 million
Cash FlowGBX 48.02 per share
Book ValueGBX 764.60 per share

Profitability

Miscellaneous

Employees2,900
Market Cap£2.06 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive GNS News and Ratings via Email

Sign-up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter.


Genus (LON:GNS) Frequently Asked Questions

How has Genus' stock been impacted by COVID-19 (Coronavirus)?

Genus' stock was trading at GBX 3,472 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, GNS stock has decreased by 8.9% and is now trading at GBX 3,164. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Genus?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genus in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Genus.

How often does Genus pay dividends? What is the dividend yield for Genus?

Genus declared a dividend on Thursday, February 27th. Stockholders of record on Thursday, March 5th will be paid a dividend of GBX 9.40 per share on Thursday, April 2nd. This represents a yield of 0.3%. The ex-dividend date of this dividend is Thursday, March 5th. The official announcement can be seen at this link. View Genus' dividend history.

What price target have analysts set for GNS?

6 Wall Street analysts have issued 12-month target prices for Genus' stock. Their forecasts range from GBX 2,685 to GBX 3,550. On average, they expect Genus' share price to reach GBX 3,226.17 in the next twelve months. This suggests a possible upside of 2.0% from the stock's current price. View analysts' price targets for Genus.

Has Genus been receiving favorable news coverage?

Press coverage about GNS stock has trended very negative this week, InfoTrie reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Genus earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutGenus.

Who are some of Genus' key competitors?

What other stocks do shareholders of Genus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genus investors own include Clinigen Group (CLIN), Glencore (GLEN), Tesco (TSCO), AstraZeneca (AZN), British American Tobacco Plc Ads (BATS), Dairy Crest Group (DCG), Debenhams (DEB), Diageo (DGE), Experian (EXPN) and Ferguson (FERG).

Who are Genus' key executives?

Genus' management team includes the following people:
  • Mr. Karim Bitar, CEO & Exec. Director (Age 54)
  • Mr. Stephen Wilson, Group Fin. Director & Exec. Director (Age 59)
  • Dr. Jonathan Lightner, Chief of R&D and Scientific Officer
  • Mr. Dan Hartley, Group Gen. Counsel & Company Sec.
  • Ms. Angelle R. Rosata, Group HR Director

What is Genus' stock symbol?

Genus trades on the London Stock Exchange (LON) under the ticker symbol "GNS."

How do I buy shares of Genus?

Shares of GNS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Genus' stock price today?

One share of GNS stock can currently be purchased for approximately GBX 3,164.

How big of a company is Genus?

Genus has a market capitalization of £2.06 billion and generates £520.40 million in revenue each year. Genus employs 2,900 workers across the globe. View additional information about Genus.

What is Genus' official website?

The official website for Genus is http://www.genusplc.com/.

How can I contact Genus?

Genus' mailing address is Matrix House, Basing View, BASINGSTOKE, RG21 4DZ, United Kingdom. The company can be reached via phone at +44-1256-347100.


MarketBeat Community Rating for Genus (LON GNS)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  339 (Vote Outperform)
Underperform Votes:  282 (Vote Underperform)
Total Votes:  621
MarketBeat's community ratings are surveys of what our community members think about Genus and other stocks. Vote "Outperform" if you believe GNS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/3/2020 by MarketBeat.com Staff

Featured Article: The risks of owning bonds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel